Andrew currently serves as the Chairman of the Board at Lotus Pharmaceutical Co., Ltd, as an Independent Director of Fubon Life Insurance and as an Independent Director at Crown Bioscience.
Andrew has initiated and conducted several large-scale IPO, M&A and fund-raising cases when he was with the financial giants. Andrew was the General Manager of JP Morgan Securities, Chief Investment Officer of ABN AMRO Asset Management, and Managing Director of Macquarie Capital Greater China.
He has been known for sound financial structure optimization and market cap expansion when he was with corporates. On the business strategy side, Andrew served as the Chief Finance Officer of Lite-On Technology and Chief Strategy Officer of Chicony Electronics.
Andrew received his MBA degree from The University of Chicago, Graduate School of Business and an M.S. degree in electrical and computer engineering from the University of Massachusetts at Amherst.
